首页 > 最新文献

The Clinician最新文献

英文 中文
Medical treatment of obesity: peculiarities of medical treatments, information, responsibility and relation to medical treatment of obesity of patients 肥胖症的医疗:肥胖症患者的医疗特点、信息、责任及其与医疗的关系
Pub Date : 2019-08-25 DOI: 10.17650/1818-8338-2019-13-1-2-27-33
O. Lerman, Yy. V. Lukina, N. Kutishenko, S. Martsevich
The aim to evaluate medical appointments, as well as awareness, adherence and attitude of patients to medical treatment of obesity based on the results of a survey of patients with a prospective outpatient registry.Materials and methods. Total 305 patients with obesity in the outpatient “PROFILE” register were surveyed, including self-assessment questions regarding their own body weight, prescription of obesity treatment by doctors, patients’ adherence to the implementation of these recommendations, propensity to self-medication and information about personal financial costs for the treatment of this disease. 42 (12 %) patients refused to participate in the survey. 213 people (69.8 %) who answered the questionnaire were diagnosed with obesity of the 1st degree, 63 (20.7 %) – obesity of the 2nd degree; obesity grade 3 was detected in 29 people (9.5 %). Waist circumference in women averaged 104.7 ± 12.9 cm, in men – 116.7 ± 9.6 cm – all patients had abdominal obesity. 263 (86.2 %) people had arterial hypertension, 117 (38.4 %) patients had coronary heart disease; type 2 diabetes mellitus was diagnosed in every fourth patient (85 (27.2 %) people); atrial fibrillation was diagnosed in 55 (18 %) patients; 48 (15.7 %) people had a history of myocardial infarction, 23 (7.5 %) patients had a stroke.Results. According to the survey results, only one in four patients – 77 (25.2 %) – out of 305 patients who participated in the survey knew about the possibility of drug treatment of obesity. Mostly, patients received recommendations for non-drug treatment of obesity: 242 patients (79.3 %) were recommended to reduce caloric intake, 194 (63.6 %) – increased physical activity. Only 37 (12.1 %) patients with obesity were recommended for weight correction, significantly more often they were recommended and taken by patients with 2 and 3 degrees of obesity compared to patients with obesity of 1 degree (p <0.0001). At the time of the survey, none of the patients were taking drugs to treat obesity. Previous experience of drug weight loss had 42 (13.8 %) participants of the survey. Most patients (more than 70 %), in principle, are not ready to spend money on the fight against overweight, and drugs are considered an extra item of expenditure almost 90 % of obese patients. There is a significant relationship (p = 0.008) between the severity of the disease and patients’ spending on obesity treatment in the range of 1–5 thousand rubles per month: the higher the degree of obesity, the more patients agree to spend this amount on the treatment of the disease.Conclusion. According to the results of the survey, medical treatment of obesity is prescribed by doctors rarely. Apparently, this is due to the extremely low awareness of patients about the possibilities of drug therapy in the treatment of overweight and obesity, the popularity of biologically active additives independently used by patients to reduce weight.
目的是评估医疗预约,以及意识,坚持和态度的肥胖患者的医学治疗的基础上的调查结果与前瞻性门诊登记的患者。材料和方法。对门诊“PROFILE”登记的305名肥胖患者进行了调查,包括自我评估体重、医生对肥胖治疗的处方、患者对这些建议的执行情况、自我用药倾向以及治疗该疾病的个人财务费用信息。42例(12%)患者拒绝参与调查。213人(69.8%)被诊断为1级肥胖,63人(20.7%)被诊断为2级肥胖;3级肥胖29人(9.5%)。女性平均腰围104.7±12.9 cm,男性平均腰围116.7±9.6 cm,均为腹部肥胖。有高血压263例(86.2%),冠心病117例(38.4%);1 / 4的患者被诊断为2型糖尿病(85人(27.2%));55例(18%)患者被诊断为房颤;48例(15.7%)患者有心肌梗死史,23例(7.5%)患者有卒中史。调查结果显示,在305名参与调查的患者中,每4名患者中只有77名(25.2%)患者知道药物治疗肥胖的可能性。大多数患者接受了非药物治疗的建议:242例(79.3%)患者被建议减少热量摄入,194例(63.6%)患者被建议增加体力活动。只有37例(12.1%)肥胖患者被推荐进行体重矫正,2度和3度肥胖患者推荐和接受体重矫正的频率明显高于1度肥胖患者(p <0.0001)。在进行调查时,没有一个患者正在服用治疗肥胖的药物。有过药物减肥经历的有42人(13.8%)。原则上,大多数患者(超过70%)不准备花钱与超重作斗争,几乎90%的肥胖患者认为药物是一项额外的支出。疾病的严重程度与患者每月花费1-5千卢布的肥胖治疗费用之间存在显著关系(p = 0.008):肥胖程度越高,患者越愿意花费这一数额用于治疗疾病。调查结果显示,医生很少开处方治疗肥胖。显然,这是由于患者对治疗超重和肥胖的药物治疗可能性的认识极低,以及患者独立使用生物活性添加剂来减肥的普及。
{"title":"Medical treatment of obesity: peculiarities of medical treatments, information, responsibility and relation to medical treatment of obesity of patients","authors":"O. Lerman, Yy. V. Lukina, N. Kutishenko, S. Martsevich","doi":"10.17650/1818-8338-2019-13-1-2-27-33","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-13-1-2-27-33","url":null,"abstract":"The aim to evaluate medical appointments, as well as awareness, adherence and attitude of patients to medical treatment of obesity based on the results of a survey of patients with a prospective outpatient registry.Materials and methods. Total 305 patients with obesity in the outpatient “PROFILE” register were surveyed, including self-assessment questions regarding their own body weight, prescription of obesity treatment by doctors, patients’ adherence to the implementation of these recommendations, propensity to self-medication and information about personal financial costs for the treatment of this disease. 42 (12 %) patients refused to participate in the survey. 213 people (69.8 %) who answered the questionnaire were diagnosed with obesity of the 1st degree, 63 (20.7 %) – obesity of the 2nd degree; obesity grade 3 was detected in 29 people (9.5 %). Waist circumference in women averaged 104.7 ± 12.9 cm, in men – 116.7 ± 9.6 cm – all patients had abdominal obesity. 263 (86.2 %) people had arterial hypertension, 117 (38.4 %) patients had coronary heart disease; type 2 diabetes mellitus was diagnosed in every fourth patient (85 (27.2 %) people); atrial fibrillation was diagnosed in 55 (18 %) patients; 48 (15.7 %) people had a history of myocardial infarction, 23 (7.5 %) patients had a stroke.Results. According to the survey results, only one in four patients – 77 (25.2 %) – out of 305 patients who participated in the survey knew about the possibility of drug treatment of obesity. Mostly, patients received recommendations for non-drug treatment of obesity: 242 patients (79.3 %) were recommended to reduce caloric intake, 194 (63.6 %) – increased physical activity. Only 37 (12.1 %) patients with obesity were recommended for weight correction, significantly more often they were recommended and taken by patients with 2 and 3 degrees of obesity compared to patients with obesity of 1 degree (p <0.0001). At the time of the survey, none of the patients were taking drugs to treat obesity. Previous experience of drug weight loss had 42 (13.8 %) participants of the survey. Most patients (more than 70 %), in principle, are not ready to spend money on the fight against overweight, and drugs are considered an extra item of expenditure almost 90 % of obese patients. There is a significant relationship (p = 0.008) between the severity of the disease and patients’ spending on obesity treatment in the range of 1–5 thousand rubles per month: the higher the degree of obesity, the more patients agree to spend this amount on the treatment of the disease.Conclusion. According to the results of the survey, medical treatment of obesity is prescribed by doctors rarely. Apparently, this is due to the extremely low awareness of patients about the possibilities of drug therapy in the treatment of overweight and obesity, the popularity of biologically active additives independently used by patients to reduce weight.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67771630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Community-acquired pneumonia. Diagnosis, treatment approaches 社区获得性肺炎。诊断、治疗方法
Pub Date : 2019-08-25 DOI: 10.17650/1818-8338-2019-13-1-2-55-64
A. Anderzhanova, Yu. A. Meleshkina
The article presents current data on the prevalence and etiology of community-acquired pneumonia, shows the contribution of each of the possible pathogens to the structure of the disease. The diagnostic criteria for pneumonia are given. The main algorithms for assessing the severity of pneumonia and the prognosis of the disease using different scales: CURB-65 / CRB-65, PORT (PSI), are described. The purpose of the test is to determine the place of treatment: outpatient or in the in-patient department, in the general department or in the intensive care unit. The criteria for IDSA / ATS (American Thoracic Society / American Society of Infectious Diseases), as well as the SMART-COP / SMRCO scale to determine the need for hospitalized patients in the intensive care unit, are reviewed. The Aliberti and PES scales are given, assessing the risk of the presence of resistant pathogens in community-acquired pneumonia. Modern recommendations on the empirical choice of antibacterial drugs depending on individual patient factors are presented: anamnestic indications for treatment with antimicrobials during the preceding three months, hospitalization within six months before the onset of pneumonia, the presence of comorbidities, the severity of the disease, the risk of resistant pathogens. The average therapeutic doses of antibacterial drugs for the treatment of community-acquired pneumonia in patients with normal renal function are indicated. The questions of the optimal duration of treatment of pneumonia depending on the etiology are considered, the criteria of sufficiency of antibacterial therapy are presented. The reasons for the possible ineffectiveness of the empirical antibiotic therapy of community-acquired pneumonia are described. The importance of identifying a particular form of community-acquired pneumonia – severe community-acquired pneumonia is emphasized. Described drugs for the treatment of severe community-acquired pneumonia. The issues of prevention of pneumonia were discussed, its importance in the strategy of reducing mortality according to the World Health Organization was emphasized.
本文介绍了社区获得性肺炎的流行和病因学的最新数据,显示了每种可能的病原体对疾病结构的贡献。给出了肺炎的诊断标准。描述了使用不同量表评估肺炎严重程度和疾病预后的主要算法:CURB-65 / CRB-65, PORT (PSI)。测试的目的是确定治疗的地点:门诊或在住院部,在综合科或在重症监护病房。回顾了IDSA / ATS(美国胸科学会/美国传染病学会)的标准,以及用于确定重症监护病房住院患者需求的SMART-COP / SMRCO量表。给出了Aliberti和PES量表,评估社区获得性肺炎中存在耐药病原体的风险。本文提出了根据患者个体因素经验选择抗菌药物的现代建议:前3个月内使用抗菌药物治疗的记忆指征、肺炎发病前6个月内的住院治疗、是否存在合并症、疾病的严重程度、耐药病原体的风险。分析了肾功能正常的社区获得性肺炎患者抗菌药物的平均治疗剂量。考虑到肺炎治疗的最佳持续时间取决于病因的问题,提出了充分抗菌治疗的标准。本文描述了经验性抗生素治疗社区获得性肺炎可能无效的原因。强调了确定一种特殊形式的社区获得性肺炎——严重社区获得性肺炎的重要性。描述了治疗严重社区获得性肺炎的药物。会议讨论了预防肺炎的问题,强调了预防肺炎在世界卫生组织规定的降低死亡率战略中的重要性。
{"title":"Community-acquired pneumonia. Diagnosis, treatment approaches","authors":"A. Anderzhanova, Yu. A. Meleshkina","doi":"10.17650/1818-8338-2019-13-1-2-55-64","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-13-1-2-55-64","url":null,"abstract":"The article presents current data on the prevalence and etiology of community-acquired pneumonia, shows the contribution of each of the possible pathogens to the structure of the disease. The diagnostic criteria for pneumonia are given. The main algorithms for assessing the severity of pneumonia and the prognosis of the disease using different scales: CURB-65 / CRB-65, PORT (PSI), are described. The purpose of the test is to determine the place of treatment: outpatient or in the in-patient department, in the general department or in the intensive care unit. The criteria for IDSA / ATS (American Thoracic Society / American Society of Infectious Diseases), as well as the SMART-COP / SMRCO scale to determine the need for hospitalized patients in the intensive care unit, are reviewed. The Aliberti and PES scales are given, assessing the risk of the presence of resistant pathogens in community-acquired pneumonia. Modern recommendations on the empirical choice of antibacterial drugs depending on individual patient factors are presented: anamnestic indications for treatment with antimicrobials during the preceding three months, hospitalization within six months before the onset of pneumonia, the presence of comorbidities, the severity of the disease, the risk of resistant pathogens. The average therapeutic doses of antibacterial drugs for the treatment of community-acquired pneumonia in patients with normal renal function are indicated. The questions of the optimal duration of treatment of pneumonia depending on the etiology are considered, the criteria of sufficiency of antibacterial therapy are presented. The reasons for the possible ineffectiveness of the empirical antibiotic therapy of community-acquired pneumonia are described. The importance of identifying a particular form of community-acquired pneumonia – severe community-acquired pneumonia is emphasized. Described drugs for the treatment of severe community-acquired pneumonia. The issues of prevention of pneumonia were discussed, its importance in the strategy of reducing mortality according to the World Health Organization was emphasized.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67771880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of the effectiveness of selection of women for coronarography in real clinical practice 临床实践中女性冠状造影选择的有效性分析
Pub Date : 2019-08-25 DOI: 10.17650/1818-8338-2019-13-1-2-34-40
N. Izmozherova, A. Popov, V. E. Sherstobitov
Objective: evaluation of the effectiveness of selection for coronary angiography of women who have applied to a cardiologist for thoracalgia and dorsalgia and regarded primarily as having a clinic of stable angina.Materials and methods. 108 women (median age 59.5) applying to cardiologist due to chest pain were included in a cross-sectional study and underwent coronary angiography. Subjects with identified clinically significant atherosclerotic coronary lesions were compared to persons with intact coronary arteries.Results. One-, two- and three-vessel lesions were diagnosed in accordingly 16; 21 and 26 % of patients. Intact coronary arteries were detected in 37 % subjects. In 17 of 40 persons with intact structure of the coronary arteries spasm of the coronary arteries was diagnosed. Odds ratio for atherosclerotic coronary arteries lesions in type 2 diabetic persons were 7.91 (1.74–36.00), for hypertension odds ratio 4.79 (1.52–15.01). Severe angina (3 and 4 functional class) was significantly more often diagnosed in women with identified coronary atherosclerosis. Severe coronary atherosclerosis was associated with absence of negative or doubtful results, whereas intact coronary vessels, negative and questionable results revealed more than half of the women. The obtained data reflect the relevance of the development of more effective algorithms for diagnosis of coronary artery disease in women, since the gender peculiarities of the formation of coronary atherosclerosis have been clearly confirmed in a number of large studies.Conclusion. Medical history, physical load tests results, and subject’s emotional status should be evaluated to assess the feasibility of coronary angiography.
目的:评估因胸痛和背痛向心脏病专家申请并主要被视为具有稳定型心绞痛临床的女性冠状动脉造影选择的有效性。材料和方法。108名因胸痛向心脏病专家申请的女性(中位年龄59.5岁)被纳入一项横断面研究,并接受了冠状动脉造影。将具有明确临床意义的动脉粥样硬化性冠状动脉病变的受试者与冠状动脉完整的人进行比较。后果在相应的16例中,诊断出一、二和三血管病变;21和26%的患者。37%的受试者检测到完整的冠状动脉。在40名冠状动脉结构完整的人中,有17人被诊断为冠状动脉痉挛。2型糖尿病患者动脉粥样硬化性冠状动脉病变的比值比为7.91(1.74–36.00),高血压比值比为4.79(1.52–15.01)。严重心绞痛(3级和4级功能性心绞痛)在确诊为冠状动脉粥样硬化的女性中更常见。严重的冠状动脉粥样硬化与阴性或可疑结果的缺失有关,而完整的冠状血管、阴性和可疑结果显示超过一半的女性。所获得的数据反映了开发更有效的算法来诊断女性冠状动脉疾病的相关性,因为冠状动脉粥样硬化形成的性别特征已在许多大型研究中得到明确证实。结论应评估病史、身体负荷测试结果和受试者的情绪状态,以评估冠状动脉造影的可行性。
{"title":"Analysis of the effectiveness of selection of women for coronarography in real clinical practice","authors":"N. Izmozherova, A. Popov, V. E. Sherstobitov","doi":"10.17650/1818-8338-2019-13-1-2-34-40","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-13-1-2-34-40","url":null,"abstract":"Objective: evaluation of the effectiveness of selection for coronary angiography of women who have applied to a cardiologist for thoracalgia and dorsalgia and regarded primarily as having a clinic of stable angina.Materials and methods. 108 women (median age 59.5) applying to cardiologist due to chest pain were included in a cross-sectional study and underwent coronary angiography. Subjects with identified clinically significant atherosclerotic coronary lesions were compared to persons with intact coronary arteries.Results. One-, two- and three-vessel lesions were diagnosed in accordingly 16; 21 and 26 % of patients. Intact coronary arteries were detected in 37 % subjects. In 17 of 40 persons with intact structure of the coronary arteries spasm of the coronary arteries was diagnosed. Odds ratio for atherosclerotic coronary arteries lesions in type 2 diabetic persons were 7.91 (1.74–36.00), for hypertension odds ratio 4.79 (1.52–15.01). Severe angina (3 and 4 functional class) was significantly more often diagnosed in women with identified coronary atherosclerosis. Severe coronary atherosclerosis was associated with absence of negative or doubtful results, whereas intact coronary vessels, negative and questionable results revealed more than half of the women. The obtained data reflect the relevance of the development of more effective algorithms for diagnosis of coronary artery disease in women, since the gender peculiarities of the formation of coronary atherosclerosis have been clearly confirmed in a number of large studies.Conclusion. Medical history, physical load tests results, and subject’s emotional status should be evaluated to assess the feasibility of coronary angiography.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42961696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical case of systemic amyloidosis in a cardiologists’s practice 心脏病专家实践中的一例系统性淀粉样变性临床病例
Pub Date : 2019-08-25 DOI: 10.17650/1818-8338-2019-13-1-2-72-79
V. G. Okorokov, O. V. Evsina, V. A. Fomina, G. Ivanova, E. S. Soldatov, D. V. Dianov, K. A. Tkachenko, A. V. Ganyuta
The aim of the work was to study the clinical case of systemic amyloidosis.Materials and methods. Patient Ch., 63 уears old, have admitted to the regional cardiological dispensary with complaints of short stabbing pains in the heart, without reaction to nitroglycerin, interruptions in the work of the heart, mainly at night, shortness of breath with little exertion, weakness, swelling of the legs and feet in September 2018. Sick from April 2016, when was dyspnea on exertion. The high level of creatinine, normochromic anemia have detected. In June 2016 chronic pyelonephritis was diagnosed. In August 2018, a right-sided hydrothorax was diagnosed, a pleural puncture was performed.Results. Laboratory and instrumental research methods were performed. Based on anamnesis data (normochromic anemia, proteinuria, increased creatinine in the blood), clinical picture, data of instrumental studies (restrictive cardiomyopathy, bilateral hydrothorax) clinical diagnosis was made: systemic amyloidosis the kidneys and heart with chronic kidney disease C5 and chronic heart failure. Histological evidence of amyloid and determination of the variant of amyloidosis by immunohistochemical method was recommended. But the patient died before the study. The histological verification of the diagnosis was carried out at the autopsy.Conclusion. This clinical observation is an example of late diagnosis of systemic amyloidosis and postmortal verification of the diagnosis, which is associated with the nonspecific symptoms and the rapidly progressing course of the disease. This case is interesting because amyloidosis proceeded under the guise of other diseases, quickly led to the development of severe heart and renal failure and to the death of the patient before verifying the disease.
目的是研究全身性淀粉样变的临床病例。材料和方法。患者Ch., 63岁уears,于2018年9月因心脏短刺痛而入院,对硝酸甘油无反应,心脏工作中断,主要在夜间,呼吸急促,很少用力,虚弱,腿脚肿胀。2016年4月发病,用力时呼吸困难。肌酐水平高,可检出正色性贫血。2016年6月诊断为慢性肾盂肾炎。2018年8月,确诊右侧胸水,行胸膜穿刺。进行了实验室和仪器研究方法。根据健忘症资料(常色性贫血、蛋白尿、血肌酐增高)、临床图片、仪器检查资料(限制性心肌病、双侧胸水),临床诊断:肾心系统性淀粉样变合并慢性肾病C5、慢性心力衰竭。建议采用淀粉样蛋白的组织学证据和免疫组织化学方法确定淀粉样变的变异。但病人在研究前就去世了。在尸检中对诊断进行了组织学验证。本临床观察是系统性淀粉样变性的晚期诊断和死后诊断验证的一个例子,这与非特异性症状和疾病的快速进展有关。这个病例很有趣,因为淀粉样变在其他疾病的幌子下发展,迅速导致严重的心脏和肾脏衰竭,并在确诊疾病之前导致患者死亡。
{"title":"A clinical case of systemic amyloidosis in a cardiologists’s practice","authors":"V. G. Okorokov, O. V. Evsina, V. A. Fomina, G. Ivanova, E. S. Soldatov, D. V. Dianov, K. A. Tkachenko, A. V. Ganyuta","doi":"10.17650/1818-8338-2019-13-1-2-72-79","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-13-1-2-72-79","url":null,"abstract":"The aim of the work was to study the clinical case of systemic amyloidosis.Materials and methods. Patient Ch., 63 уears old, have admitted to the regional cardiological dispensary with complaints of short stabbing pains in the heart, without reaction to nitroglycerin, interruptions in the work of the heart, mainly at night, shortness of breath with little exertion, weakness, swelling of the legs and feet in September 2018. Sick from April 2016, when was dyspnea on exertion. The high level of creatinine, normochromic anemia have detected. In June 2016 chronic pyelonephritis was diagnosed. In August 2018, a right-sided hydrothorax was diagnosed, a pleural puncture was performed.Results. Laboratory and instrumental research methods were performed. Based on anamnesis data (normochromic anemia, proteinuria, increased creatinine in the blood), clinical picture, data of instrumental studies (restrictive cardiomyopathy, bilateral hydrothorax) clinical diagnosis was made: systemic amyloidosis the kidneys and heart with chronic kidney disease C5 and chronic heart failure. Histological evidence of amyloid and determination of the variant of amyloidosis by immunohistochemical method was recommended. But the patient died before the study. The histological verification of the diagnosis was carried out at the autopsy.Conclusion. This clinical observation is an example of late diagnosis of systemic amyloidosis and postmortal verification of the diagnosis, which is associated with the nonspecific symptoms and the rapidly progressing course of the disease. This case is interesting because amyloidosis proceeded under the guise of other diseases, quickly led to the development of severe heart and renal failure and to the death of the patient before verifying the disease.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43560239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary infective endocarditis with isolated involvement of the pulmonary valve not associated with drug addiction 原发性感染性心内膜炎伴肺动脉瓣孤立性受累与药物成瘾无关
Pub Date : 2019-08-25 DOI: 10.17650/1818-8338-2019-13-1-2-65-71
N. Chipigina, N. Karpova, M. M. Tulinov, E. V. Golovko, L. M. Goloukhova, V. S. Kornienko, A. Kostin, V. Barsegyan
Objective: to describe a rare case of infective endocarditis (IE) with isolated localization in the pulmonary valve (PV).Materials and methods. We observed primary IE with isolated localization in the PV in a 27-year-old female patient without risk factors of right-side IE.Results. The disease was caused by Streptococcus gordonii and proceeded acutely with typical signs of right-side IE: fever above 38 °С, chills, clinical picture of bilateral septic embolic abscess pneumonia, as well as secondary anemia, secondary thrombocytopenia, and glomerulonephritis. Echocardiography showed large vegetations in the PV prolapsing in the right ventricle and pulmonary artery.Conclusion. IE with localization in the PV should be suspected in patients with fever and clinical picture of septic embolic pneumonia in absence of other embolic situations.
目的:描述一例罕见的肺动脉瓣孤立定位感染性心内膜炎。材料和方法。我们在一名没有右侧IE危险因素的27岁女性患者中观察到原发性IE在PV中孤立定位。结果。该疾病由戈登氏链球菌引起,并急性发展为右侧IE的典型症状:发烧超过38°С,寒战,双侧脓毒性栓塞性脓肿肺炎的临床表现,以及继发性贫血、继发性血小板减少症,和肾小球肾炎。超声心动图显示右心室和肺动脉PV增生中有大量的赘生物。结论在没有其他栓塞情况下,发烧和感染性栓塞性肺炎临床表现的患者应怀疑PV定位的IE。
{"title":"Primary infective endocarditis with isolated involvement of the pulmonary valve not associated with drug addiction","authors":"N. Chipigina, N. Karpova, M. M. Tulinov, E. V. Golovko, L. M. Goloukhova, V. S. Kornienko, A. Kostin, V. Barsegyan","doi":"10.17650/1818-8338-2019-13-1-2-65-71","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-13-1-2-65-71","url":null,"abstract":"Objective: to describe a rare case of infective endocarditis (IE) with isolated localization in the pulmonary valve (PV).Materials and methods. We observed primary IE with isolated localization in the PV in a 27-year-old female patient without risk factors of right-side IE.Results. The disease was caused by Streptococcus gordonii and proceeded acutely with typical signs of right-side IE: fever above 38 °С, chills, clinical picture of bilateral septic embolic abscess pneumonia, as well as secondary anemia, secondary thrombocytopenia, and glomerulonephritis. Echocardiography showed large vegetations in the PV prolapsing in the right ventricle and pulmonary artery.Conclusion. IE with localization in the PV should be suspected in patients with fever and clinical picture of septic embolic pneumonia in absence of other embolic situations.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41489320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents 比什凯克市居民血脂异常患病率的年龄和性别特征
Pub Date : 2019-04-01 DOI: 10.17650/1818-8338-2019-12-3-4-37-44
T. Murataliev, V. K. Zventsovа, Z. T. Radzhapova, I. V. Kalinicheva, N. Z. Zhanyshbekova, U. E. Sultan, S. Mukhtarenko
Т. М. Мураталиев1, 2, В. К. Звенцова1, З. Т. Раджапова2, И. В. Калиничева3, Н. Ж. Жанышбекова1, Султан у.Э.1, С. Ю. Мухтаренко1 Национальный центр кардиологии и терапии им. акад. Мирсаида Миррахимова; Кыргызская Республика, 720 040 Бишкек, ул. Тоголок Молдо, 3; Кыргызско-российский славянский университет им. первого Президента России Б. Н. Ельцина; Кыргызская Республика, 720 000 Бишкек, ул. Киевская, 44; ОсОО «Интелмед» – «Лаборатория Бонецкого»; Кыргызская Республика, 720 082 Бишкек, ул. Шабдан Баатыра, 6
T.页:1穆拉塔列夫1,2,V。附件连环1,Z。T.拉贾波瓦B.其他事项Kalinicheva,v.G.Zhanyshbekova 1,苏丹U.E.1,c。于Mukhtarenko1阿卡德Mirsaida Mirrahimova;吉尔吉斯共和国比什凯克市,720040号Togolok Moldo,3;吉尔吉斯-俄罗斯斯拉夫大学俄罗斯第一任总统B。H.叶利钦;吉尔吉斯共和国,720000比什凯克基辅,44;INTELMED——博内茨基实验室;吉尔吉斯共和国比什凯克市,720082号Shabdan Baatira,6岁
{"title":"Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents","authors":"T. Murataliev, V. K. Zventsovа, Z. T. Radzhapova, I. V. Kalinicheva, N. Z. Zhanyshbekova, U. E. Sultan, S. Mukhtarenko","doi":"10.17650/1818-8338-2019-12-3-4-37-44","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-12-3-4-37-44","url":null,"abstract":"Т. М. Мураталиев1, 2, В. К. Звенцова1, З. Т. Раджапова2, И. В. Калиничева3, Н. Ж. Жанышбекова1, Султан у.Э.1, С. Ю. Мухтаренко1 Национальный центр кардиологии и терапии им. акад. Мирсаида Миррахимова; Кыргызская Республика, 720 040 Бишкек, ул. Тоголок Молдо, 3; Кыргызско-российский славянский университет им. первого Президента России Б. Н. Ельцина; Кыргызская Республика, 720 000 Бишкек, ул. Киевская, 44; ОсОО «Интелмед» – «Лаборатория Бонецкого»; Кыргызская Республика, 720 082 Бишкек, ул. Шабдан Баатыра, 6","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67771134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016 2011-2016年克里米亚共和国注册的抗高血压药物不良反应分析
Pub Date : 2019-04-01 DOI: 10.17650/1818-8338-2019-12-3-4-21-29
A. V. Matveev, A. E. Krasheninnikov, E. Egorova, A. G. Dormidor
The aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016. Materials and methods . We studied notification cards about AR registered in the regional database of spontaneous messages ARCADe. We analyzed 211 notification cards about AR in patients with proven arterial hypertension diagnosis (ICD code П0—П5). Results. Drugs from the groups of angiotensin-converting enzyme inhibitors and slow calcium channel blockers most often cause AR, among them enalapril and amlodipine are the absolute leaders. AR occurred less frequently in application of drugs from the groups of в-blockers and angiotensin IIreceptor blockers. The study of the clinical manifestations of AR showed that most of them were allergic reactions of varying severity (skin itch, urticaria, swelling of lips, eyelids, tongue). The number of such cases was 70 (33.2 %) from all registered cases of AR on antihypertensive drugs. Examination of the outcomes of AR in patients taking antihypertensive drugs showed that the development of temporary disability was observed in 19 (9 %) cases, the hospitalization of outpatients as a result of AR development on drugs was required in 7 (3.3 %) cases, and in 2 cases patients had to prolong hospitalization. Life-threatening conditions in the form of Quincke’s edema were reported in 13patients. In the remaining 170 (80.6 %) cases AR were not serious and did not cause the above consequences. Assessment of AR severity revealed that mild AR were most common, much less often antihypertensive drugs caused severe AR (the incidence ranged from 5 to 13 %, depending on the method for severity assessment). Conclusion . The obtained results confirm our previously published data that in the structure of AR on antihypertensive drugs, bulk of the reports associated with angiotensin-converting enzyme inhibitors. Most often antihypertensive drugs caused mild AR.
本研究的目的是分析和调查2011-2016年期间居住在克里米亚共和国的患者对用于动脉高压治疗的药物的不良反应(AR)的严重程度。材料和方法。我们研究了在区域自发消息数据库ARCADe中注册的AR通知卡。我们分析了211张关于确诊为动脉高压患者AR的通知卡(ICD代码П0-П5)。后果血管紧张素转换酶抑制剂和慢钙通道阻滞剂组的药物最常引起AR,其中依那普利和氨氯地平是绝对的领导者。血管紧张素受体阻滞剂组和血管紧张素II受体阻滞剂组的AR发生率较低。AR的临床表现研究表明,大多数是不同严重程度的过敏反应(皮肤瘙痒、荨麻疹、嘴唇、眼睑、舌头肿胀)。此类病例的数量为70例(33.2%),占所有注册的服用抗高血压药物的AR病例。对服用降压药的患者AR结果的检查显示,19例(9%)患者出现暂时性残疾,7例(3.3%)患者因药物引起AR而需要住院治疗,2例患者不得不延长住院时间。据报道,13名患者出现了以昆克水肿形式危及生命的情况。在其余170例(80.6%)病例中,AR并不严重,也没有造成上述后果。AR严重程度评估显示,轻度AR最常见,降压药导致严重AR的频率要低得多(发病率在5%至13%之间,具体取决于严重程度评估方法)。结论所获得的结果证实了我们之前发表的数据,即在抗高血压药物的AR结构中,大部分报告与血管紧张素转换酶抑制剂有关。抗高血压药物通常会引起轻度AR。
{"title":"Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016","authors":"A. V. Matveev, A. E. Krasheninnikov, E. Egorova, A. G. Dormidor","doi":"10.17650/1818-8338-2019-12-3-4-21-29","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-12-3-4-21-29","url":null,"abstract":"The aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016. Materials and methods . We studied notification cards about AR registered in the regional database of spontaneous messages ARCADe. We analyzed 211 notification cards about AR in patients with proven arterial hypertension diagnosis (ICD code П0—П5). Results. Drugs from the groups of angiotensin-converting enzyme inhibitors and slow calcium channel blockers most often cause AR, among them enalapril and amlodipine are the absolute leaders. AR occurred less frequently in application of drugs from the groups of в-blockers and angiotensin IIreceptor blockers. The study of the clinical manifestations of AR showed that most of them were allergic reactions of varying severity (skin itch, urticaria, swelling of lips, eyelids, tongue). The number of such cases was 70 (33.2 %) from all registered cases of AR on antihypertensive drugs. Examination of the outcomes of AR in patients taking antihypertensive drugs showed that the development of temporary disability was observed in 19 (9 %) cases, the hospitalization of outpatients as a result of AR development on drugs was required in 7 (3.3 %) cases, and in 2 cases patients had to prolong hospitalization. Life-threatening conditions in the form of Quincke’s edema were reported in 13patients. In the remaining 170 (80.6 %) cases AR were not serious and did not cause the above consequences. Assessment of AR severity revealed that mild AR were most common, much less often antihypertensive drugs caused severe AR (the incidence ranged from 5 to 13 %, depending on the method for severity assessment). Conclusion . The obtained results confirm our previously published data that in the structure of AR on antihypertensive drugs, bulk of the reports associated with angiotensin-converting enzyme inhibitors. Most often antihypertensive drugs caused mild AR.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41317576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Факторы риска респираторных осложнений у пациентов в периоперационном периоде 术后病人呼吸并发症的风险因素
Pub Date : 2019-04-01 DOI: 10.17650/1818-8338-2019-12-3-4-15-20
Д. П. Котова, В. С. Шеменкова
Diseases of the respiratory system (both acute and exacerbations of chronic ones) remain the most frequent non-surgical complications after surgical interventions of various sizes, increasing the duration of the patient»s hospital stay, increasing economic costs and the percentage of deaths. It was shown that respiratory complications developed after abdominal operations increased the risk of 30-day mortality by 10 times. The most common complications include: reintubation, acute respiratory failure, pulmonary edema, atelectasis and pneumonia. The development of respiratory complications is due to the pathology of the respiratory system and respiratory muscles. It is proved that the use of drugs that inhibit neuromuscular conduction in 75 % of cases provokes the development of atelectasis, respiratory muscle dysfunction and reduces respiratory volumes. Respiratory complications are most often caused by hypoxia or hypercapnia. Hypoxia is characterized by a decrease in the partial pressure of oxygen and is well corrected by additional oxygenation. In the first hours after surgery hypoxemia occurs in 50—55 % of cases with a decrease in saturation up to 80 %. Complete normalization of respiratory dysfunction usually occurs 4—6 hours after extubation. Hypercapnia, on the contrary, is characterized by an increase in the partial pressure of oxygen, the phenomena of hyperkalemia and respiratory acidosis. Correction of electrolyte and buffer disturbances is necessary. It is important for the Clinician to remember the need to identify possible risk factors for respiratory complications (modifiable and unmodified) and ways to correct them. Examination of the patient by a therapist before the planned operation, including possible preoperative preparation in the therapeutic departments of a multidisciplinary hospital helps to reduce the frequency of postoperative complications. In this article the authors describe recommendations for evaluation, prevention and diagnosis of respiratory complications in the perioperative period in patients with comorbid pathology.
呼吸系统疾病(包括急性和慢性疾病的恶化)仍然是各种规模的手术干预后最常见的非手术并发症,增加了患者的住院时间,增加了经济成本和死亡率。研究表明,腹部手术后出现的呼吸并发症使30天内死亡的风险增加了10倍。最常见的并发症包括:再插管、急性呼吸衰竭、肺水肿、肺不张和肺炎。呼吸道并发症的发生是由于呼吸系统和呼吸肌肉的病理。事实证明,在75%的病例中,使用抑制神经肌肉传导的药物会引起肺不张、呼吸肌功能障碍和呼吸量减少。呼吸系统并发症最常由缺氧或高碳酸血症引起。缺氧的特征是氧气分压的降低,通过额外的氧合可以很好地纠正。在手术后的第一个小时内,50 - 55%的病例发生低氧血症,饱和度下降高达80%。呼吸功能完全恢复正常通常发生在拔管后4-6小时。相反,高碳酸血症的特点是氧分压增加,出现高钾血症和呼吸性酸中毒现象。电解质和缓冲扰动的校正是必要的。对于临床医生来说,重要的是要记住需要识别可能的呼吸系统并发症的危险因素(可修改的和未修改的)以及纠正它们的方法。在计划手术前由治疗师对患者进行检查,包括在多学科医院的治疗部门进行可能的术前准备,有助于减少术后并发症的发生。在这篇文章中,作者描述了评估,预防和诊断围手术期呼吸并发症患者的共病病理的建议。
{"title":"Факторы риска респираторных осложнений у пациентов в периоперационном периоде","authors":"Д. П. Котова, В. С. Шеменкова","doi":"10.17650/1818-8338-2019-12-3-4-15-20","DOIUrl":"https://doi.org/10.17650/1818-8338-2019-12-3-4-15-20","url":null,"abstract":"Diseases of the respiratory system (both acute and exacerbations of chronic ones) remain the most frequent non-surgical complications after surgical interventions of various sizes, increasing the duration of the patient»s hospital stay, increasing economic costs and the percentage of deaths. It was shown that respiratory complications developed after abdominal operations increased the risk of 30-day mortality by 10 times. The most common complications include: reintubation, acute respiratory failure, pulmonary edema, atelectasis and pneumonia. The development of respiratory complications is due to the pathology of the respiratory system and respiratory muscles. It is proved that the use of drugs that inhibit neuromuscular conduction in 75 % of cases provokes the development of atelectasis, respiratory muscle dysfunction and reduces respiratory volumes. Respiratory complications are most often caused by hypoxia or hypercapnia. Hypoxia is characterized by a decrease in the partial pressure of oxygen and is well corrected by additional oxygenation. In the first hours after surgery hypoxemia occurs in 50—55 % of cases with a decrease in saturation up to 80 %. Complete normalization of respiratory dysfunction usually occurs 4—6 hours after extubation. Hypercapnia, on the contrary, is characterized by an increase in the partial pressure of oxygen, the phenomena of hyperkalemia and respiratory acidosis. Correction of electrolyte and buffer disturbances is necessary. It is important for the Clinician to remember the need to identify possible risk factors for respiratory complications (modifiable and unmodified) and ways to correct them. Examination of the patient by a therapist before the planned operation, including possible preoperative preparation in the therapeutic departments of a multidisciplinary hospital helps to reduce the frequency of postoperative complications. In this article the authors describe recommendations for evaluation, prevention and diagnosis of respiratory complications in the perioperative period in patients with comorbid pathology.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"12 1","pages":"15-20"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67771003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PULMONARY-RENAL SYNDROME: DIFFICULTIES OF DIFFERENTIAL DIAGNOSIS 肺肾综合征:鉴别诊断的难点
Pub Date : 2018-11-30 DOI: 10.17650/1818-8338-2018-2-43-50
D. Y. Andriyashkina, N. Demidova, N. Shostak, N. A. Tutaev, A. D. Ershov, D. K. Dudin
The study objective is to demonstrate the difficulty of differential diagnosis in pulmonary-renal syndrome using a clinical case as an example.Materials and methods. Male patient A., 68 years old, retired, was hospitalized at the N.I. Pirogov City Clinical Hospital № 1 in December of 2017 with complaints of inefficient cough, fever of 39 °С, weakness, apnea, weight loss up 10 kg in 3 months. Examination revealed skin and mucosa paleness, calf edema, heart beat of 102 bpm, normal rhythm, arterial pressure 130/80 mm Hg, respiratory rate 22 breaths per min. Auscultation revealed harsh respiration in the lungs, weakened in the lower parts, fine moist rales. Anemia (hemoglobin – 53 g/l, erythrocytes – 1.85 × 1012/l, serum iron – 3.1 µmol/l), elevated urea up to 41.4 mmol/l, creatinine up to 843.1 µmol/l (glomerular filtration rate – 6 ml/min/1.73 m2), leukocytes up to 12.5 × 109/l, С-reactive protein up to 124.96 mg/l were diagnosed. Clinical urine analysis showed proteinuria 0.47 g/l. Computed tomography of the chest revealed pronounced infiltrative changes in tissues of both lungs, more on the right, alveolitis, bronchiolitis in the middle lobe on the right, 5th segment on the left. Lymphadenopathy mediastinal was diagnosed. After examination (multiple bacteriological blood, sputum tests, interferon-gamma release assay, echocardiography, bronchoalveolar lavage, sterna puncture, esophagogastroduodenoscopy, colonoscopy, etc.), oncological pathology, tuberculosis of the lungs, sepsis, infections endocarditis and other infectious pathologies were excluded. Antibacterial courses prescribed earlier were ineffective. Immunological blood test revealed high titers (1:1280) of antineutrophil cytoplasmic antibodies (ANCA) with perinuclear fluorescence type (myeloperoxidase specificity), negative antibodies to glomerular basal membrane which allowed to diagnose ANCA-associated vasculitis.Results. Considering the data of clinical, lab, and instrumental examination, the patient was diagnosed with microscopic polyangiitis, ANCA-associated, affecting the lungs (disseminated interstitial lung disease with bronchiolitis) and kidneys (rapidly progressive glomerulonephritis), intrathoracic lymphadenopathy, activity grade III (BVAS index – 23 points). Grade II respiratory failure. Chronic kidney disease 5D (glomerular filtration rate – 6 ml/min/1.73 m2). Grade II arterial hypertension, risk 4. Grade II pulmonary hypertension. Chronic heart failure 2А, functional class IV. Mixed anemia (iron-deficient, chronic disease), severe. Disseminated polyposis of the colon (hyperplastic type). At the hospital, antibacterial drugs (cefoperazone sulbactam), antifungal (fluticasone) were administered, anemia was corrected (iron-containing drugs and erythropoietin, hemotransfusion), hemodialysis. Cyclophosphane 400 mg was administered intravenously, a week later – 800 mg. Methylprednisolone (60 mg/day), co-trimoxazole (480 mg 3 times a week) were prescribed. A pronounced improvement w
研究的目的是证明鉴别诊断的困难肺肾综合征,以一个临床病例为例。材料和方法。男性患者A, 68岁,退休,于2017年12月在N.I. Pirogov市第一临床医院住院,主诊为无效咳嗽,发烧39°С,虚弱,呼吸暂停,3个月内体重减轻10公斤。检查示皮肤及黏膜苍白,小腿水肿,心跳102次/分,心律正常,动脉压130/80毫米汞柱,呼吸频率22次/分。听诊示肺呼吸粗重,下半部分减弱,细音湿音。贫血(血红蛋白- 53 g/l,红细胞- 1.85 × 1012/l,血清铁- 3.1µmol/l),尿素升高至41.4 mmol/l,肌酐升高至843.1µmol/l(肾小球滤过率- 6 ml/min/1.73 m2),白细胞升高至12.5 × 109/l, С-reactive蛋白升高至124.96 mg/l。临床尿分析:蛋白尿0.47 g/l。胸部ct示双肺组织明显浸润性改变,右侧多见,右侧肺泡炎,中叶细支炎,左侧第五肺段。诊断为纵隔淋巴结病。经检查(多项细菌学血、痰、干扰素- γ释放试验、超声心动图、支气管肺泡灌洗、胸骨穿刺、食管胃十二指肠镜、结肠镜等),排除肿瘤病理、肺结核、脓毒症、感染性心内膜炎等感染性病理。早先开的抗菌疗程无效。免疫血检显示抗中性粒细胞胞浆抗体(ANCA)滴度高(1:1280),核周荧光型(髓过氧化物酶特异性),肾小球基底膜抗体阴性,可诊断ANCA相关血管炎。综合临床、实验室及仪器检查资料,诊断为显微镜下多血管炎,anca相关,累及肺部(弥散性间质性肺病伴细支气管炎)和肾脏(快速进行性肾小球肾炎),胸内淋巴结病变,活动度III级(BVAS指数- 23分)。II级呼吸衰竭。慢性肾病5D(肾小球滤过率- 6ml /min/1.73 m2)。II级动脉高血压,风险4。II级肺动脉高压。慢性心力衰竭2А,功能四级。混合性贫血(缺铁,慢性疾病),严重。结肠弥散性息肉病(增生性)。在医院,给予抗菌药物(头孢哌酮舒巴坦),抗真菌药物(氟替卡松),纠正贫血(含铁药物和促红细胞生成素,输血),血液透析。静脉注射环磷酰胺400毫克,一周后- 800毫克。甲强的松龙(60毫克/天),复方新诺明(480毫克/周3次)。由于治疗,观察到明显的改善:体温正常化,呼吸暂停,咳嗽,虚弱,食欲增加。患者出院时建议继续按治疗方案进行细胞抑制治疗,并在住院地进行程序性血液透析。结论:本病例提示在鉴别诊断肺肾综合征时考虑anca相关血管炎的必要性。及时诊断和积极的细胞抑制剂治疗在治疗中起主要作用,促进疾病进展的减缓和预后的改善。
{"title":"PULMONARY-RENAL SYNDROME: DIFFICULTIES OF DIFFERENTIAL DIAGNOSIS","authors":"D. Y. Andriyashkina, N. Demidova, N. Shostak, N. A. Tutaev, A. D. Ershov, D. K. Dudin","doi":"10.17650/1818-8338-2018-2-43-50","DOIUrl":"https://doi.org/10.17650/1818-8338-2018-2-43-50","url":null,"abstract":"The study objective is to demonstrate the difficulty of differential diagnosis in pulmonary-renal syndrome using a clinical case as an example.Materials and methods. Male patient A., 68 years old, retired, was hospitalized at the N.I. Pirogov City Clinical Hospital № 1 in December of 2017 with complaints of inefficient cough, fever of 39 °С, weakness, apnea, weight loss up 10 kg in 3 months. Examination revealed skin and mucosa paleness, calf edema, heart beat of 102 bpm, normal rhythm, arterial pressure 130/80 mm Hg, respiratory rate 22 breaths per min. Auscultation revealed harsh respiration in the lungs, weakened in the lower parts, fine moist rales. Anemia (hemoglobin – 53 g/l, erythrocytes – 1.85 × 1012/l, serum iron – 3.1 µmol/l), elevated urea up to 41.4 mmol/l, creatinine up to 843.1 µmol/l (glomerular filtration rate – 6 ml/min/1.73 m2), leukocytes up to 12.5 × 109/l, С-reactive protein up to 124.96 mg/l were diagnosed. Clinical urine analysis showed proteinuria 0.47 g/l. Computed tomography of the chest revealed pronounced infiltrative changes in tissues of both lungs, more on the right, alveolitis, bronchiolitis in the middle lobe on the right, 5th segment on the left. Lymphadenopathy mediastinal was diagnosed. After examination (multiple bacteriological blood, sputum tests, interferon-gamma release assay, echocardiography, bronchoalveolar lavage, sterna puncture, esophagogastroduodenoscopy, colonoscopy, etc.), oncological pathology, tuberculosis of the lungs, sepsis, infections endocarditis and other infectious pathologies were excluded. Antibacterial courses prescribed earlier were ineffective. Immunological blood test revealed high titers (1:1280) of antineutrophil cytoplasmic antibodies (ANCA) with perinuclear fluorescence type (myeloperoxidase specificity), negative antibodies to glomerular basal membrane which allowed to diagnose ANCA-associated vasculitis.Results. Considering the data of clinical, lab, and instrumental examination, the patient was diagnosed with microscopic polyangiitis, ANCA-associated, affecting the lungs (disseminated interstitial lung disease with bronchiolitis) and kidneys (rapidly progressive glomerulonephritis), intrathoracic lymphadenopathy, activity grade III (BVAS index – 23 points). Grade II respiratory failure. Chronic kidney disease 5D (glomerular filtration rate – 6 ml/min/1.73 m2). Grade II arterial hypertension, risk 4. Grade II pulmonary hypertension. Chronic heart failure 2А, functional class IV. Mixed anemia (iron-deficient, chronic disease), severe. Disseminated polyposis of the colon (hyperplastic type). At the hospital, antibacterial drugs (cefoperazone sulbactam), antifungal (fluticasone) were administered, anemia was corrected (iron-containing drugs and erythropoietin, hemotransfusion), hemodialysis. Cyclophosphane 400 mg was administered intravenously, a week later – 800 mg. Methylprednisolone (60 mg/day), co-trimoxazole (480 mg 3 times a week) were prescribed. A pronounced improvement w","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48478237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PREVALENCE AND DYNAMICS OF ENDOTHELIAL DYSFUNCTION, CAROTID AND CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE 慢性风湿性心脏病患者内皮功能障碍、颈动脉和冠状动脉粥样硬化的患病率和动态
Pub Date : 2018-11-30 DOI: 10.17650/1818-8338-2018-12-2-22-27
V. S. Petrov
The aim of study was to assess the prevalence and 5-year dynamics of atherosclerosis and endothelial dysfunction in patients with chronic rheumatic heart disease (CRHD). Materials and methods. 205 patients with CRHD were examined. Endothelial function was assessed by “AngioScan-01”, ultrasound examination of carotid arteries was performed, and some patients underwent coronaronagiography. The comparison group consisted from 57 patients with aortic stenosis (AS). Results. In both groups endothelial dysfunction was observed in large (–6.77 ± 0.89 ms – in CRHD group, –6.68 ± 0.04 ms – in AS group) and small (1.73 ± 0.05 – in CRHD group, 1.51 ± 0.04 – in AS group) arteries. Within 5 years of observation in patients with CRHD statistically significant decrease was observed in occlusion index in amplitude (1.5 ± 0.037) and in phase shift between the channels before and after occlusion (–3.13 ± 0.94). It is important that during this period there was no significant deterioration in parameters of echocardiography and 6-minute walk test. Atherosclerosis of coronary arteries was revealed in 33.3 % patients with CRHD and in 52.5 % patients with AS. According to the ultrasound of the neck vessels in 188 patients with CRHD, the average thickness of intima/media complex was 0.84 ± 0.01 on the left and 0.84 ± 0.01 on the right; frequency of atherosclerotic plaques in the carotid arteries was 72.3 % on the left and 68.08 % on the right. The thickness of intima/media complex was statistically significantly higher in patients with AS on the left (1.02 ± 0.02) and on the right (1.15 ± 0.07); frequency of atherosclerotic plaques in the carotid arteries was 93.2 % on the left and 90.9 % on the right. Assessment of ultrasound data dynamics of carotid arteries in patients with CRHD revealed statistically significant increasing of intima/media thickness on the left (0.88 ± 0.01) and on the right (0.9 ± 0.01). There were no statistically significant differences for speed parameters. Conclusions. Endothelial dysfunction takes place in the presence of mitral stenosis or AS, it is more expressed in AS. Also, atherosclerosis of carotid arteries in patients with CRHD and AS is more prevalent than in the population. And the frequency of coronary atherosclerosis in patients with CRHD is insignificant in comparison with patients with AS. Within 5 years of observation both endothelial dysfunction and atherosclerosis of carotid arteries progress in patients with CRHD.
{"title":"PREVALENCE AND DYNAMICS OF ENDOTHELIAL DYSFUNCTION, CAROTID AND CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE","authors":"V. S. Petrov","doi":"10.17650/1818-8338-2018-12-2-22-27","DOIUrl":"https://doi.org/10.17650/1818-8338-2018-12-2-22-27","url":null,"abstract":"The aim of study was to assess the prevalence and 5-year dynamics of atherosclerosis and endothelial dysfunction in patients with chronic rheumatic heart disease (CRHD). Materials and methods. 205 patients with CRHD were examined. Endothelial function was assessed by “AngioScan-01”, ultrasound examination of carotid arteries was performed, and some patients underwent coronaronagiography. The comparison group consisted from 57 patients with aortic stenosis (AS). Results. In both groups endothelial dysfunction was observed in large (–6.77 ± 0.89 ms – in CRHD group, –6.68 ± 0.04 ms – in AS group) and small (1.73 ± 0.05 – in CRHD group, 1.51 ± 0.04 – in AS group) arteries. Within 5 years of observation in patients with CRHD statistically significant decrease was observed in occlusion index in amplitude (1.5 ± 0.037) and in phase shift between the channels before and after occlusion (–3.13 ± 0.94). It is important that during this period there was no significant deterioration in parameters of echocardiography and 6-minute walk test. Atherosclerosis of coronary arteries was revealed in 33.3 % patients with CRHD and in 52.5 % patients with AS. According to the ultrasound of the neck vessels in 188 patients with CRHD, the average thickness of intima/media complex was 0.84 ± 0.01 on the left and 0.84 ± 0.01 on the right; frequency of atherosclerotic plaques in the carotid arteries was 72.3 % on the left and 68.08 % on the right. The thickness of intima/media complex was statistically significantly higher in patients with AS on the left (1.02 ± 0.02) and on the right (1.15 ± 0.07); frequency of atherosclerotic plaques in the carotid arteries was 93.2 % on the left and 90.9 % on the right. Assessment of ultrasound data dynamics of carotid arteries in patients with CRHD revealed statistically significant increasing of intima/media thickness on the left (0.88 ± 0.01) and on the right (0.9 ± 0.01). There were no statistically significant differences for speed parameters. Conclusions. Endothelial dysfunction takes place in the presence of mitral stenosis or AS, it is more expressed in AS. Also, atherosclerosis of carotid arteries in patients with CRHD and AS is more prevalent than in the population. And the frequency of coronary atherosclerosis in patients with CRHD is insignificant in comparison with patients with AS. Within 5 years of observation both endothelial dysfunction and atherosclerosis of carotid arteries progress in patients with CRHD.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67770823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Clinician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1